Image Courtesy: YouTube/UNIDO
A Japanese university has launched what it says is the world’s first fully automated medical research laboratory operated entirely by robots, marking a major step toward AI-driven scientific experimentation with minimal human involvement.
The new facility, developed by the Institute of Science Tokyo at its Yushima campus, currently uses 10 robots to conduct laboratory work traditionally performed by researchers. Among them is the humanoid Maholo LabDroid, a dual-armed robot capable of handling delicate procedures such as transferring reagents, operating temperature-controlled instruments, and performing automated cell cultivation tasks, according to Japan Today.
The university plans to scale the operation aggressively over the next 15 years, with a target of deploying roughly 2,000 robots by 2040. Researchers involved in the project say the long-term objective is to automate nearly the entire medical research pipeline, from generating hypotheses to validating experimental results.
The initiative reflects a broader push across the biotech and pharmaceutical industries to combine robotics with artificial intelligence in an effort to reduce costs, improve reproducibility, and address growing labor shortages in scientific research. Automated systems can operate continuously with consistent precision, reducing the risk of human error in repetitive or highly sensitive experiments.
Maholo LabDroid has already been used in clinical research environments, including an ophthalmology-focused hospital in Kobe where it assists with stem cell and automated cell culture work. The technology is designed to handle laboratory tasks that often require fine motor control and strict environmental conditions, areas that have historically been difficult to automate fully.
Japan’s project also arrives amid rising global interest in humanoid robotics for laboratory environments. Earlier this year, US-based biotech company Insilico Medicine introduced a humanoid robot called Supervisor into its AI-powered drug discovery lab. The company says the system is intended to support scientific workflows ranging from telepresence monitoring to advanced laboratory manipulation tasks.
One of the biggest challenges facing fully autonomous laboratories is that most scientific equipment was originally designed for human operators. Humanoid robots are increasingly viewed as a practical workaround because they can interact with existing instruments and infrastructure without requiring labs to be rebuilt around specialized automation hardware.
The trend could significantly reshape pharmaceutical development over the coming decade. AI systems are already being used to identify biological targets, model molecular behavior, and accelerate drug candidate discovery. Adding autonomous robotic execution to that pipeline could compress research timelines while increasing laboratory throughput, especially in areas such as regenerative medicine and personalized therapeutics.